U.S. Stem Cell Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$3.62 M |
Shares Outstanding |
393.7 M |
Public Float |
337.13 M |
Address |
13794 NW 4th Street Sunrise Florida 33325 United States |
Employees | - |
Website | http://www.us-stemcell.com |
Updated | 07/08/2019 |
U. S. Stem Cell, Inc. engages on the discovery, development, and subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. |